Expanding Delivery of an Evidence-based Weight-loss Intervention to Enhance Access and Reach Underserved Groups After TBI

The goal of this clinical trial is to extend the accessibility of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) modified for people with TBI (GLB-TBI) to reduce health inequities and reach a broad and diverse sample.To increase the accessibility and reach of the GLB-TBI we will conduct a randomized control trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-TBI (tGLB-TBI). Results will provide a scalable telehealth weight-loss program that clinicians and community workers across the country can use to help people with TBI lose weight and improve health.

Inclusion Criteria:18-64 years of ageGreater than or equal to 6 months post traumatic brain injury (TBI)Moderate to severe TBI at time of injuryBody Mass Index greater than or equal to 25Able to participate in physical activityWilling to use a tablet/computer/smartphone (either personal device or one provided by the research team)Exclusion Criteria:Contraindications to physical activity (e.g., uncontrolled hypertension, unstable angina, severe joint disease, uncontrolled vertigo/dizziness)Not fluent in the English languageLow cognitive functionResiding in a hospital, acute rehabilitation facility, or skilled nursing facilityDiagnosed with or taking medications for Type 2 diabetesSelf-reported pregnancyPre-existing diagnosis of an eating disorder